11 August 2016
TAKEDA:Canada follows USA (2015) in approving proteasome inhibitor NINLARO (ixazonib) for :Plasma cell Ca. after one course of treatment
ORAL NINLARO will be combined with Calgene's ORAL REVLIMID ( lenalidomide) and ORAL dexamethazone.
Subscribe to:
Posts (Atom)